lipidomics | GenomeWeb

lipidomics

Scientists from the Colorado School of Mines have proposed a method to complement mass spec-based protein profiling. 

NEW YORK (GenomeWeb News) – The Icahn School of Medicine at Mt. Sinai and biopharmaceutical firm Berg today announced a five-year partnership aimed at cancer, as well as central nervous system and endocrine disorders.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific is the exclusive worldwide marketer and distributor of MKI Knowledge Industry's lipidomic research data software, under a deal announced today.

NEW YORK (GenomeWeb News) – Agilent Technologies and Premier Biosoft today said they will support the combination of each other's technologies to advance lipidomics research.

NEW YORK (GenomeWeb News) – AB Sciex and the University of Wollongong in Australia today announced a research partnership aimed at developing lipid analysis capabilities.

NEW YORK (GenomeWeb News) – Premier Biosoft today announced a co-marketing and reselling deal with AB Sciex for lipidomic research software.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Shimadzu and the University of Tokyo today announced a collaboration to develop technologies aimed at lipidomic biomarkers.

The companies will co-market mass spectrometry tools with characterization software.

The goal of the partnership is to develop workflow solutions that will allow researchers a better understanding of disease states.

The purchase comes as part of a £2 million ($3.3 million) award to establish the Cambridge Lipidomics Biomarker Research Initiative.

Pages

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.